Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Kidney Int Rep. 2016 Jun 11;1(2):73–84. doi: 10.1016/j.ekir.2016.05.002

Table 1.

Demographics and clinical characteristics at study enrollment

Variable

Number of patients 13

  Sex %
    Male/ Female 56/44

Age at diagnosis (yr) 49.9 +/− 13.4

Race or ethnic group (%)
    White/Black/Asian/Hispanic 68/13/13/6

Serum creatinine (mg/dL) 1.36±0.14
eGFR CKD-EPI (ml/min/1.73 m2) 62 ±23

Proteinuria (grams/24 h) 10.8 ± 2.8

Serum albumin (g/dL) 1.8±0.5

Hypertension 67%

Urinary abnormalities (% patients)

Dipstick
- Hemoglobin ≥1+ 81%
- Glucosuria≥1+ 23%
Sediment (microscopic examination)
- Dysmorphic RBC/acanthocytes 68%
- RBC casts 0%
- Fatty casts 43%
- Fat droplets 100%

Study enrollment defined as initiation of protocol immunosuppressive drugs. Data presented as mean ±SD for continuous variables.